Viewing Study NCT01654250


Ignite Creation Date: 2025-12-24 @ 5:25 PM
Ignite Modification Date: 2025-12-29 @ 4:39 AM
Study NCT ID: NCT01654250
Status: COMPLETED
Last Update Posted: 2016-02-03
First Post: 2012-04-27
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Sponsor: Pfizer
Organization:

Study Overview

Official Title: A Multicenter, Dose-optimized, Double-blind, Randomized, Placebo-controlled Study To Evaluate The Efficacy Of Nwp09 In Pediatric Patients With Attention Deficit Hyperactivity Disorder (Adhd) In A Laboratory Classroom
Status: COMPLETED
Status Verified Date: 2016-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The safety and efficacy of a chewable formulation of extended-release methylphenidate will be studied in children with ADHD
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
B7491005 OTHER Alias Study Number View